Trials / Completed
CompletedNCT00389025
Mast-Cell Stabilizing Effects of Olopatadine
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To assess the effects of olopatadine of the release of mast cell histamine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olopatadine (generic name) |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-04-01
- First posted
- 2006-10-17
- Last updated
- 2016-11-22
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00389025. Inclusion in this directory is not an endorsement.